Dr. Reddy’s Laboratories Ltd., an India-based pharmaceutical company with ADRs listed on the New York Stock Exchange recently disclosed that it “has commenced a detailed investigation into an anonymous complaint.”

According to this filing: “The complaint alleges that healthcare professionals in Ukraine and potentially in other countries were provided with improper benefits in violation of U.S. laws. The investigation is being carried out by a reputed independent U.S. law firm.”

The post Indian Issuer Discloses Investigation appeared first on FCPA Professor.